Related Experiment Video
Updated: Jan 18, 2026

Novel and Innovative Hybrid Technique for Type A Aortic Dissection
Published on: March 28, 2025
Single-Branched Stent-Graft for Thoracic Aortic Diseases Involving Left Subclavian Artery
Xunqiang Liu1, Zheng Jia1, Huanjun Chen1
1Department of Vascular Intervention, Yan'an Hospital, Kunming Medical University, Kunming, China.
Purpose:
To assess the clinical benefits and complications of thoracic endovascular aneurysm repair (TEVAR) using a single-branched stent-graft in patients with thoracic aortic diseases (TADs) involving the left subclavian artery (LSA).
Methods:
This retrospective study reviewed patients with TADs involving the LSA treated with TEVAR using a unibody single-branched stent-graft (Castor single-branched stent-graft, Shanghai MicroPort Endovascular (Group) MedTech Co., Ltd.) from November 2017 to May 2021. Clinical follow-ups and computed tomographic angiography (CTA) were conducted at 1 week, 3 months, 6 months, and annually.
Results:
A total of 114 patients underwent TEVAR with Castor stent-graft. Among 114 patients, 88 had TBAD, 14 had PAU, 6 had pseudoaneurysms, 3 had TAA, and 2 had IMH. Technical success (defined as successful deployment and patency of all stent segments) was 100%. No mortality, endoleak, stroke, or paraplegia was observed during a mean follow-up of 19.8 months. One case of LSA occlusion (0.9%) was noted at 3-month follow-up, without neurological symptoms.
Conclusion:
The Castor single-branched stent-graft is effective for treating TADs involving the LSA, with high technical success and no short- or midterm complications. Further research is needed to confirm long-term safety and efficacy.
Related Concept Videos
Thoracic Aorta
The Arch of Aorta
Encircling the heart, the coronary arteries form a ring-like structure before...
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Cardiac Catheterization III: Left Heart Catheterization

